Medicines Database
All patients, whether fighting a deadly disease or managing a chronic condition, live in hope of new medicines and improved therapies. America's research based biopharmaceutical companies are meeting these hopes with new medicines and treatments that improve health and give patients and physicians better treatment options.
America's research-based biopharmaceutical companies are committed to continuing and expanding innovative research and developing new and better medicines and treatments. Every year, dozens of new medicines and therapies are added to the medical arsenal in the fight against disease. These new medicines are part of the steady-stream of medical and therapeutic advances that are revolutionizing and improving healthcare. They are the result of medical research and development that can take as long as 15 years and cost more than $800 million dollars to bring a new medicine from the laboratory to a pharmacy shelf.
Disease is our common enemy. These medicines and therapies in development described below are giving patients and physicians new weapons in the fight against disease.
HIV/AIDS
As the war against AIDS enters its third decade, pharmaceutical companies are continuing to research new weapons to thwart this persistent and deadly enemy. Learn more about what America's pharmaceutical companies are doing to fight the war on AIDS.more
Biotechnology
By using the body's own tools and weapons to fight disease, pharmaceutical and biotechnology companies are developing more and better medicines. Learn more about how America's pharmaceuticall and biotechnology companies are leading the way in the search for cures.
moreCancer
Until recently, killing cancer cells without harming healthy cells in the body has proven to be extraordinarily hard. But that's changing. Right now, America's pharmaceutical company researchers are creating new "smart" medicines that ignore healthy cells and go straight to the cancer. Learn more about how America's pharmaceutical companies are fighting cancer.
moreChildren
Until recently, killing cancer cells without harming healthy cells in the body has proven to be extraordinarily hard. But that's changing. Right now, America's pharmaceutical company researchers are creating new "smart" medicines that ignore healthy cells and go straight to the cancer. Learn more about how America's pharmaceutical companies are fighting cancer.
moreHeart Disease and Stroke
According to a new industry survey, 122 new medicines currently are in development to treat – and hopefully beat – heart disease and stroke, two of the top three causes of death in the United States. Learn more about how America's phramaceutical companies are leading the way in the search for cures.
moreInfectious Disease
As the age-old war against infectious diseases enters a new—and frightening—phase, pharmaceutical and biotechnology companies are rising to the heightened challenges. Learn more about how America's phramaceutical and biotechnology companies are leading the forefront during this new era.
moreMental Illness
One hundred and three medicines are in the pharma-ceutical pipeline to help the more than 50 million Americans who suffer from some form of mental illness — from Alzheimer's disease to depression to schizophrenia to substance dependence. Learn more about how America's pharmaceutical companies are leading the way in the search for cures.
moreNeurological Disorders
A new survey found 176 new medicines in development for neurologic diseases - up from 138 when the previous survey was conducted in 1999. More than 100 pharmaceutical and biotechnology companies are conducting this research - learn more about what we are doing to lead the way in the search for cures.
moreNew Drug Approvals
Medicines target proteins. Create a medicine that targets the right protein and you can save a life, stop a heart attack, even find a way to prevent cancer. That's precisely what America¹s pharmaceutical company researchers are doing right now. They¹re taking dead aim against cancer, heart disease, Alzheimer¹s, HIV/AIDS, and a host of other diseases. Find out what new drug approvals are coming down the pipe this year.
Older Americans
The population of Americans over 65 is surging and the pace will only increase in the next couple of years. Indeed, beginning in just five short years, the first of more than 70 million members of the baby-boom generation will begin retiring and further swell the number of Americans over 65. As life expectancy continues to expand, older Americans face new and growing challenges to their health, productivity and independence-- geriatric conditions to complications from diseases like cancer, cardiovascular disease and diabetes.
Women
Pharmaceutical companies are targeting more than 30 diseases that disproportionately affect women, with 358 medicines in development for these diseases. Learn more about how America's pharmaceutical companies are leading the way in the search for cures.
moreHispanic Americans
Pharmaceutical and biotechnology companies are developing 245 new medicines for diseases that disproportionately affect the nation’s 35.3 million Hispanic Americans, according to a new survey by the Pharmaceutical Research and Manufacturers of America (PhRMA). Learn more about our work in the search for cures.
moreAfrican Americans
In a continuing drive to close the health gap between African Americans and the majority population, pharmaceutical and biotechnology companies are developing 249 new medicines for disease that disproportionately afflict African Americans or diseases that are among the top 10 causees of death among African Americans, according to a new survey.
more